ZEBRASCI – YOUR PREFFERED PARTNER

We are passionate about developing and launching combination products.

Medical Device and Biopharmaceutical companies gain an edge by utilizing ZebraSci. Our technologies, combination product development services and ISO/IEC 17025:2017 accredited testing lab provide the resources you need for your medical device and combination product development project.  Whether you require support with flexible engineering clean room fill / finish activities, mechanical performance testing, or container closure integrity testing, ZebraSci can help.

Our experienced team has provided solutions for drug delivery devices and combination products for nearly ten years. Our cross-functional team is geared to deliver thoughtful, integrated solutions to your device projects. We’re not your ordinary CRO – we’ve got you covered from Concept to Commercialization.

TRACK RECORD

ZebraSci has helped launch over 30 combination products

Proven Results

By combining experience, a unique methodology, customized tools and a passion for results, we help our clients accelerate their combination product development programs.

TESTING

Our in-house, independent test labs have all the solutions you need

Advanced Capabilities

Our ISO/IEC 17025:2017 accredited testing laboratories for medical device, drug delivery & combination product development provide expert support for your product.

TECHNOLOGY

Our advanced automated inspection machines are state of the art

Our Innovative Tech

Our innovative inspection products help you characterize silicone oil coverage, particulates, fill volume, dimensional characteristics and visual defects of primary containers.

Our Approach

We partner with our clients from concept to commercialization for combination product development. ZebraSci’s experienced team can help you select primary containers, establish device performance specifications, develop design verification testing plans and execute all the required testing. Our complaint handling, root cause analysis, and final lot release programs help you manage your device post-launch. Our consultation and highly-developed validation and qualification procedures, ensure that your device comes to market on time, on budget and in compliance with ISO 13485:2016 and FDA 21 CFR 820.